Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers	Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Peritoneal Diseases, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, endometrium neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneal neoplasm, uterine disorder	Recruiting	Phase 2	2026-07-16		NCT06906341

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Corcept Therapeutics	9

49 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
004	Birmingham	United States	1
014	San Francisco	United States	1
108	Leuven	Belgium	2
114	Madrid	Spain	1
115	Barcelona	Spain	2
121	Milwaukee	United States	1
122	Milan	Italy	1
124	Rome	Italy	1
127	Pittsburgh	United States	1
150	Palo Alto	United States	1
255	Berlin	Germany	1
292	Albuquerque	United States	1
293	Torino	Italy	1
295	Pavia	Italy	1
300	Norfolk	United States	1
304	Centerville	United States	1
306	Lille	France	1
307	Nancy	France	1
308	Toulouse	France	1
310	Nice	France	1
319	Treviso	Italy	1
321	Catania	Italy	1
323	Plérin	France	1
324	Pierre-Bénite	France	1
325	Hasselt	Belgium	1

Clinical trials